Compagnie Lombard Odier S Cm A Inovio Pharmaceuticals, Inc. Transaction History

Compagnie Lombard Odier S Cm A

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 27, 2022	SELL	$2.97 - $5.2 $3,267 - $5,720	-1,100 Closed	0 $0
Q1 2021 Apr 23, 2021	BUY	$8.81 - $16.96 $9,691 - $18,656	1,100 New	1,100 $10,000
Q3 2020 Nov 12, 2020	SELL	$9.57 - $27.05 $0 - $0	0 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$7.14 - $31.69 $0 - $0	0 New	0 $0
Q3 2017 Nov 14, 2017	SELL	$5.36 - $6.37 $10,720 - $12,740	-2,000 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	2,000	2,000 $16,000

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $496M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Compagnie Lombard Odier S Cm A, based on Form 13F filings with the SEC.

Stay updated on Compagnie Lombard Odier S Cm A with notifications on news.